This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Sep 15;7(18 Suppl):S105-6.

doi: 10.1016/s1359-6446(02)02385-1.

Expanding the HTS paradigm

PMID: 12546874
DOI: 10.1016/s1359-6446(02)02385-1

Editorial

Expanding the HTS paradigm

James Inglese. Drug Discov Today. 2002.

. 2002 Sep 15;7(18 Suppl):S105-6.

doi: 10.1016/s1359-6446(02)02385-1.

Author

PMID: 12546874
DOI: 10.1016/s1359-6446(02)02385-1

No abstract available

PubMed Disclaimer

Similar articles

Current trends in high-throughput screening.
Sterling J, Bojanic D, Eglen RM, Heyse S, Strulovici B. Sterling J, et al. Assay Drug Dev Technol. 2008 Aug;6(4):491-504. doi: 10.1089/adt.2008.9989. Assay Drug Dev Technol. 2008. PMID: 18795872 No abstract available.
Cellular platforms for HTS: three case studies.
Johnston PA, Johnston PA. Johnston PA, et al. Drug Discov Today. 2002 Mar 15;7(6):353-63. doi: 10.1016/s1359-6446(01)02140-7. Drug Discov Today. 2002. PMID: 11893544 Review.
Origin and evolution of high throughput screening.
Pereira DA, Williams JA. Pereira DA, et al. Br J Pharmacol. 2007 Sep;152(1):53-61. doi: 10.1038/sj.bjp.0707373. Epub 2007 Jul 2. Br J Pharmacol. 2007. PMID: 17603542 Free PMC article. Review.
[Achievements of physicochemical biology and the outlook for the creation of new antimicrobial preparations].
[No authors listed] [No authors listed] Antibiot Med Biotekhnol. 1985 Oct;30(10):723-5. Antibiot Med Biotekhnol. 1985. PMID: 4091510 Russian. No abstract available.
Attrition in the drug discovery process: lessons to be learned from the safety pharmacology paradigm.
Curtis MJ, Pugsley MK. Curtis MJ, et al. Expert Rev Clin Pharmacol. 2012 May;5(3):237-40. doi: 10.1586/ecp.12.22. Expert Rev Clin Pharmacol. 2012. PMID: 22697586 No abstract available.

See all similar articles

Cited by

Use of a Fission Yeast Platform to Identify and Characterize Small Molecule PDE Inhibitors.
Hoffman CS. Hoffman CS. Front Pharmacol. 2022 Jan 17;12:833156. doi: 10.3389/fphar.2021.833156. eCollection 2021. Front Pharmacol. 2022. PMID: 35111072 Free PMC article. Review.
Are In Vitro Cytotoxicity Assessments of Environmental Samples Useful for Characterizing the Risk of Exposure to Multiple Contaminants at the Workplace? A Systematic Review.
Viegas C, Pena P, Gomes B, Dias M, Aranha Caetano L, Viegas S. Viegas C, et al. Toxics. 2022 Feb 5;10(2):72. doi: 10.3390/toxics10020072. Toxics. 2022. PMID: 35202258 Free PMC article. Review.
Toxicity testing in the 21st century: a vision and a strategy.
Krewski D, Acosta D Jr, Andersen M, Anderson H, Bailar JC 3rd, Boekelheide K, Brent R, Charnley G, Cheung VG, Green S Jr, Kelsey KT, Kerkvliet NI, Li AA, McCray L, Meyer O, Patterson RD, Pennie W, Scala RA, Solomon GM, Stephens M, Yager J, Zeise L. Krewski D, et al. J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):51-138. doi: 10.1080/10937404.2010.483176. J Toxicol Environ Health B Crit Rev. 2010. PMID: 20574894 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science